Clinical trial
Metronidazole for Pulmonary Tuberculosis (South Korea)
NCT00425113 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00425113 |
|---|---|
| Title | Metronidazole for Pulmonary Tuberculosis (South Korea) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Metronidazole Combined With Antituberculous Chemotherapy vs. Antituberculous Chemotherapy With Placebo in Subjects With Multi-Drug Resistant Pulmonary Tuberculosis |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Tuberculosis, Multi-Drug Resistant Tuberculosis |
| Intervention type | Drug, Procedure |
| Interventions | Metronidazole, Blood Draw, CT Scan, PET Scan |
| Enrollment | 35 |
| Start date | Dec 1, 2006 |
| Primary completion | Oct 1, 2012 |
| Completion | Feb 1, 2013 |
| First posted | Jan 22, 2007 |
| Last update posted | Jul 10, 2013 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: